| Systematic (IUPAC) name | |
|---|---|
| (8β)-6-methyl-8-(piperidin-1-ylcarbonyl)-9,10-didehydroergoline | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 50485-23-9 |
| ATC code | ? |
| PubChem | CID 308707 |
| Chemical data | |
| Formula | C21H25N3O |
| Mol. mass | 335.442 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
LSD-Pip is a compound from the ergoline family, related to LSD but with the N,N-diethyl substitution replaced by a piperidine group. It is more potent than the corresponding pyrrolidine and morpholine analogues (LPD-824 and LSM-775 respectively), but is still several times less potent than LSD as a 5-HT2A agonist.[1] Early studies suggested this compound to be inactive as a hallucinogen in humans,[2] though this does not seem to have been confirmed by any more recent work.
|
||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)